ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
The Daily Star13d
Breathe easy: The best allergy treatments
Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...
Prevention on MSN7d
7 Ways to Stop Post-Nasal Drip, According to Doctors
Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
Rolling Out8d
Why your sore throat could be allergies or something worse
Learn how allergies and other conditions can cause a sore throat, and how to identify the right treatment based on your ...
Seasonal allergy treatments: VERIFY Fact Sheet
Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.
Everything you need to know about dust mite allergies as 'life changing' pill offered on NHS
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...
'Life-changing' treatment could help thousands of people with severe dust mite allergy
The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...
Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...